Research ArticleAccepted Article
Placebo response in rheumatoid arthritis clinical trials
Katie Bechman, Mark Yates, Sam Norton, Andrew Cope and James B. Galloway
The Journal of Rheumatology May 2019, jrheum.190008; DOI: https://doi.org/10.3899/jrheum.190008
Katie Bechman
From the Department of Inflammation Biology, Academic Rheumatology, Kings College London, United Kingdom; Psychology Department, Institute of Psychiatry, Kings College London, United Kingdom. Disclosure statement: J.B.G. has received honoraria for speaking or attending conferences from Pfizer, Bristol-Myers Squibb, UCB and Celgene. Role of the Funding source: This work was primarily supported by Medical Research Council as a Clinical Training Research Fellowship to KB (CTRF- MR/R001332/1 to K Bechman). Address correspondence to Katie Bechman MBCHB, BSC, Kings College London, Department of Inflammation Biology, Academic Rheumatology Room 3.46, Third Floor, Weston Education Centre, King’s College London, London SE5 9RJ. E-mail: katie.bechman@kcl.ac.uk
Mark Yates
From the Department of Inflammation Biology, Academic Rheumatology, Kings College London, United Kingdom; Psychology Department, Institute of Psychiatry, Kings College London, United Kingdom. Disclosure statement: J.B.G. has received honoraria for speaking or attending conferences from Pfizer, Bristol-Myers Squibb, UCB and Celgene. Role of the Funding source: This work was primarily supported by Medical Research Council as a Clinical Training Research Fellowship to KB (CTRF- MR/R001332/1 to K Bechman). Address correspondence to Katie Bechman MBCHB, BSC, Kings College London, Department of Inflammation Biology, Academic Rheumatology Room 3.46, Third Floor, Weston Education Centre, King’s College London, London SE5 9RJ. E-mail: katie.bechman@kcl.ac.uk
Sam Norton
From the Department of Inflammation Biology, Academic Rheumatology, Kings College London, United Kingdom; Psychology Department, Institute of Psychiatry, Kings College London, United Kingdom. Disclosure statement: J.B.G. has received honoraria for speaking or attending conferences from Pfizer, Bristol-Myers Squibb, UCB and Celgene. Role of the Funding source: This work was primarily supported by Medical Research Council as a Clinical Training Research Fellowship to KB (CTRF- MR/R001332/1 to K Bechman). Address correspondence to Katie Bechman MBCHB, BSC, Kings College London, Department of Inflammation Biology, Academic Rheumatology Room 3.46, Third Floor, Weston Education Centre, King’s College London, London SE5 9RJ. E-mail: katie.bechman@kcl.ac.uk
Andrew Cope
From the Department of Inflammation Biology, Academic Rheumatology, Kings College London, United Kingdom; Psychology Department, Institute of Psychiatry, Kings College London, United Kingdom. Disclosure statement: J.B.G. has received honoraria for speaking or attending conferences from Pfizer, Bristol-Myers Squibb, UCB and Celgene. Role of the Funding source: This work was primarily supported by Medical Research Council as a Clinical Training Research Fellowship to KB (CTRF- MR/R001332/1 to K Bechman). Address correspondence to Katie Bechman MBCHB, BSC, Kings College London, Department of Inflammation Biology, Academic Rheumatology Room 3.46, Third Floor, Weston Education Centre, King’s College London, London SE5 9RJ. E-mail: katie.bechman@kcl.ac.uk
James B. Galloway
From the Department of Inflammation Biology, Academic Rheumatology, Kings College London, United Kingdom; Psychology Department, Institute of Psychiatry, Kings College London, United Kingdom. Disclosure statement: J.B.G. has received honoraria for speaking or attending conferences from Pfizer, Bristol-Myers Squibb, UCB and Celgene. Role of the Funding source: This work was primarily supported by Medical Research Council as a Clinical Training Research Fellowship to KB (CTRF- MR/R001332/1 to K Bechman). Address correspondence to Katie Bechman MBCHB, BSC, Kings College London, Department of Inflammation Biology, Academic Rheumatology Room 3.46, Third Floor, Weston Education Centre, King’s College London, London SE5 9RJ. E-mail: katie.bechman@kcl.ac.uk
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Placebo response in rheumatoid arthritis clinical trials
Katie Bechman, Mark Yates, Sam Norton, Andrew Cope, James B. Galloway
The Journal of Rheumatology May 2019, jrheum.190008; DOI: 10.3899/jrheum.190008